| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fate Therapeutics Inc (FATE) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. FATE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.89M | $8.31M | - | |
| CEO | 1.30M | $2.78M | - | |
| Other | 400.0K | $854.0K | - | |
| Dir | 110.0K | $234.8K | - | |
| CFO | 100.0K | $213.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2022 | Tahl Cindy79 | General Counsel And Secretary | Sell | 7,738 | $46.43 | $359,312.60 | -2.3% | -27.3% | -88.9% | |
| Jan 10, 2022 | Valamehr Bahram87 | Chief R&D Officer | Sell | 5,596 | $46.38 | $259,557.52 | -1.8% | -27.3% | -88.9% | |
| Jan 3, 2022 | Tahl Cindy79 | General Counsel And Secretary | Sale+OE | 50,000 | $59.34 | $2,966,852.75 | -6.2% | -29.7% | -83.1% | |
| Dec 20, 2021 | Dulac Edward J III81 | Chief Financial Officer | Sale+OE | 15,977 | $60.00 | $958,620.00 | -12.6% | -37.3% | -79.0% | |
| Dec 13, 2021 | Valamehr Bahram87 | Chief R&D Officer | Sale+OE | 25,000 | $47.66 | $1,191,405.50 | -2.9% | -39.4% | -66.6% | |
| Dec 10, 2021 | Chu Yu-Waye72 | Senior VP Clinical Development | Sale+OE | 7,500 | $51.46 | $385,947.94 | -0.8% | -27.8% | -61.6% | |
| Nov 18, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 20,000 | $54.27 | $1,085,400.00 | -4.8% | -34.5% | -63.9% | |
| Oct 22, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 60,000 | $59.55 | $3,572,959.65 | -4.8% | -35.1% | -67.3% | |
| Oct 1, 2021 | Tahl Cindy79 | General Counsel And Secretary | Sale+OE | 50,000 | $58.83 | $2,941,461.99 | -11.9% | +1.0% | -62.3% | |
| Sep 28, 2021 | Dulac Edward J III81 | Chief Financial Officer | Sale+OE | 19,460 | $62.53 | $1,216,833.80 | -27.1% | -4.8% | -62.0% |